Trial intelligence / Profile preview

A-PRF and HA in Impacted Mandibular Third Molar Surgery

NCT07835373Completed

Sponsor
Inonu University
Start
Aug 2025
Primary completion
Jun 2026
Countries
1
01

Overview

Randomised trial of advanced platelet-rich fibrin and sodium hyaluronate anti-adhesion barrier gel in Impacted Mandibular Third Molar (IM3M) (3 arms), sponsored by Inonu University. Primary endpoint: Fractal Dimension of the Extraction Socket at 90 days. Started Aug 2025; status: completed.

02

Drugs

advanced platelet-rich fibrinsodium hyaluronate anti-adhesion barrier gel
03

Conditions

Impacted Mandibular Third Molar (IM3M)

Beyond the preview

Go deeper on NCT07835373.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT07835373.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call